{
    "root": "2f9cb3b9-2d12-24ce-e063-6294a90a9c50",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Rufinamide",
    "value": "20250305",
    "ingredients": [
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB"
        },
        {
            "name": "HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)",
            "code": "8136Y38GY5"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "CARBOXYMETHYLCELLULOSE SODIUM",
            "code": "K679OBS311"
        },
        {
            "name": "ORANGE",
            "code": "5EVU04N5QU"
        },
        {
            "name": "POLOXAMER 188",
            "code": "LQA7B6G8JG"
        },
        {
            "name": "POTASSIUM SORBATE",
            "code": "1VPU26JZZ4"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "PROPYLPARABEN",
            "code": "Z8IX2SC1OH"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "DIMETHICONE",
            "code": "92RU3N3Y1O"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        },
        {
            "name": "SORBITOL",
            "code": "506T60A25R"
        },
        {
            "name": "RUFINAMIDE",
            "code": "WFW942PR79"
        }
    ],
    "indications": "rufinamide oral suspension indicated adjunctive treatment seizures associated lennox-gastaut syndrome pediatric patients 1 year age older adults .",
    "contraindications": "rufinamide oral suspension given food ( 2.2 ) measure oral suspension using provided adapter dosing syringe ( 2.2 ) pediatric patients 1 year older : starting daily dose : 10 mg/kg per day two equally divided doses ( 2.1 ) increase 10 mg/kg increments every day maximum dose 45 mg/kg per day , exceed 3,200 mg per day , two divided doses ( 2.1 ) adults : starting daily dose : 400 mg 800 mg per day two equally divided doses ( 2.1 ) increase 400 mg 800 mg every day maximum dose 3,200 mg per day , two divided doses , reached ( 2.1 )",
    "warningsAndPrecautions": "rufinamide oral suspension white off-white , orange flavored liquid supplied amber polyethylene terephthalate ( pet ) bottle child-resistant closure . oral suspension packaged dispenser set contains calibrated oral dosing syringe adapter . store oral suspension upright position . within 90 days first opening bottle , discard remainder . oral suspension available bottles 460 ml ( ndc 69452-223-84 ) .",
    "adverseReactions": "rufinamide contraindicated patients familial short qt syndrome [ ( 5.3 ) ] .",
    "indications_original": "Rufinamide oral suspension is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients 1 year of age and older and in adults.",
    "contraindications_original": "Rufinamide oral suspension should be given with food ( 2.2 ) Measure oral suspension using provided adapter and dosing syringe ( 2.2 ) Pediatric patients 1 year and older: Starting daily dose: 10 mg/kg per day in two equally divided doses ( 2.1 ) Increase by 10 mg/kg increments every other day to maximum dose of 45 mg/kg per day, not to exceed 3,200 mg per day, in two divided doses ( 2.1 ) Adults: Starting daily dose: 400 mg to 800 mg per day in two equally divided doses ( 2.1 ) Increase by 400 mg to 800 mg every other day until a maximum dose of 3,200 mg per day, in two divided doses, is reached ( 2.1 )",
    "warningsAndPrecautions_original": "Rufinamide oral suspension is a white to off-white, orange flavored liquid supplied in an amber polyethylene terephthalate (PET) bottle with child-resistant closure. The oral suspension is packaged with a dispenser set which contains a calibrated oral dosing syringe and an adapter. Store the oral suspension in an upright position. Use within 90 days of first opening the bottle, then discard any remainder. The oral suspension is available in bottles of 460 mL (NDC 69452-223-84).",
    "adverseReactions_original": "Rufinamide is contraindicated in patients with Familial Short QT syndrome\n \n  [\n                     see \n                     Warnings and Precautions \n                     (\n                     \n                        5.3\n                     \n                     )\n                     ]."
}